Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 6,138 LGND shares, $316.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 6,138 | $316.5K |
| Jun 16, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 3,000 | $154.7K |
| Jun 9, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 836 | n/a |
| May 12, 2026 | Odyssey Therapeutics, Inc. (ODTX) | Purchase | 1,000 | $20.0K |
| Jun 10, 2025 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 1,209 | n/a |
| Nov 20, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 137,803 | $29.0K |
| Nov 4, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 18,875 | n/a |
| Sep 12, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Purchase | 35,363 | $54.8K |
| Jun 19, 2024 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 1,252 | n/a |
| Apr 2, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 2,000 | n/a |